JBIO vs HRMY
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 17, 2026
JBIO
HRMY
Investment Advisor Scores
HRMY
AI Analyst Insights
Detailed Metrics Comparison
| Metric | JBIO | HRMY | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 10.6383 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.0% | 30.3% | HRMY |
| Earnings Growth | 0.0% | 88.2% | HRMY |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 37.9/100 | 42.2/100 | HRMY |
| Profit Margin | 0.0% | 18.9% | HRMY |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | HRMY |
Relative Price Performance (Last 90 Days)
Current Technical Phase
JBIO
NeutralMixed signals - no dominant trend phase, RSI 60
HRMY
MarkupPrice above SMA50, rising 50-day trend (7.6% over 20 days), RSI 56
Fundamentals Snapshot
| Metric | JBIO | HRMY |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -8.8 | 5.7 |
| Trailing P/E | — | 12.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.3% |
| Gross Margin | — | 0.8% |
| Operating Margin | 0.0% | 0.3% |
| EPS | -1.07 | 3.09 |
| Dividend Yield | — | — |